|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||


,


,1
* Department of Pathology,
Division of Research Immunology/BMT, Childrens Hospital Los Angeles Saban Research Institute, Los Angeles, California, USA;
The Burnham Institute Cancer Center, La Jolla, California, USA;
University of Southern California Keck School of Medicine, Los Angeles, California, USA
1Correspondence: Department of Pathology, MS# 103, Childrens Hospital Los Angeles, University of Southern California Keck School of Medicine, 4650 Sunset Blvd., Los Angeles, CA 90027 USA. E-mail: lingtaow{at}usc.edu
ABSTRACT
Acute promyelocytic leukemia (APL) cells express promyelocytic leukemia/retinoic acid receptor alpha (PML/RAR
) fusion protein, which leads to the blocking of APL cell differentiation. Treatment of APL with all-trans-retinoic acid (ATRA) induces disease remission by in vivo differentiation of APL cells. Differentiation requires cell cycle exit; yet how ATRA couples cell cycle exit to differentiation of APL remains largely unknown. We previously found that ATRA-induced cell differentiation accompanies ubiquitination-proteolysis of ménage à trois 1 (MAT1), an assembly factor and targeting subunit of cyclin-dependent kinase (CDK)-activating kinase (CAK) that regulates G1 exit. We report here that CAK binds to and phosphorylates PML/RAR
in actively proliferating APL cells. In response to ATRA, PML/RAR
is dissociated from CAK, leading to MAT1 degradation, G1 arrest, and decreased CAK phosphorylation of PML/RAR
. CAK phosphorylation of PML/RAR
is inhibited when MAT1 levels are reduced. Both MAT1 degradation and PML/RAR
hypophosphorylation occur in ATRA-induced G1-arresting cells undergoing differentiation but not in the synchronized G1 cells that do not differentiate. These findings reveal a novel ATRA signaling on APL cell differentiation, in which ATRA coordinates G1 arrest and transition into differentiation by inducing MAT1 degradation and PML/RAR
hypophosphorylation through disrupting PML/RAR
binding and phosphorylation by CAK.Wang, J.-g., Barsky, L. W., Davicioni, E., Weinberg, K. I., Triche, T. J., Zhang, X.-k., and Wu, L. Retinoic acid induces leukemia cell G1 arrest and transition into differentiation by inhibiting cyclin-dependent kinase-activating kinase binding and phosphorylation of PML/RAR
.
This article has been cited by other articles:
![]() |
C. Valli, G. Paroni, A. M. Di Francesco, R. Riccardi, M. Tavecchio, E. Erba, A. Boldetti, M. Gianni', M. Fratelli, C. Pisano, et al. Atypical retinoids ST1926 and CD437 are S-phase-specific agents causing DNA double-strand breaks: significance for the cytotoxic and antiproliferative activity Mol. Cancer Ther., September 1, 2008; 7(9): 2941 - 2954. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Luo, A. Wang, K. J. Payne, H. Peng, J.-g. Wang, Y. K. Parrish, J. W. Rogerio, T. J. Triche, Q. He, and L. Wu Intrinsic Retinoic Acid Receptor {alpha}-Cyclin-Dependent Kinase-Activating Kinase Signaling Involves Coordination of the Restricted Proliferation and Granulocytic Differentiation of Human Hematopoietic Stem Cells Stem Cells, October 1, 2007; 25(10): 2628 - 2637. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |